According to PEX Network annual report, 47 % of respondents said operational excellence and business transformation strategies are mission-critical in helping to drive growth, manage turnaround and deliver strategic objectives within organizations.
Industries are undergoing a seismic transformation, fueled by the rapid adoption of Artificial Intelligence (AI). While many organizations have made significant investments in AI, few are realizing the full potential of their efforts. According to Gartner, “Over 40% of agentic AI projects will be canceled by the end of 2027 due to escalating costs, unclear business value, or inadequate risk controls.”
Continuous Improvement (CI) has long been a proven framework for driving operational excellence. Traditionally focused on incremental gains in cost, quality, and delivery, CI initiatives often lose momentum over time due to challenges such as limited leadership engagement, initiative fatigue, and high implementation costs.
A growing number of forward-thinking organizations are bridging this gap by integrating CI and AI in a complementary, “yin and yang” approach. CI provides the structure to identify high-value opportunities and eliminate inefficiencies, while AI delivers the scale and speed to achieve breakthrough results.
Join us as industry leaders explore:
OPEX focuses on harmonizing processes, technologies, and culture and ensuring that organizations can fully leverage digital initiatives. In this session, we will explore the foundational role of operational excellence in driving continuous process improvement across the organization.
Key Discussion Points:
How AbbVie and BusinessOptix are building visibility, agility, and readiness for AI-driven transformation.
AI is reshaping the way organizations approach operational excellence, but real success depends on what comes first: building the foundation. In this fireside chat, Joy Shelledy, Director, Strategic Change Enablement, AbbVie; Amanda Swearengen, Director II, Strategic Change Enablement, AbbVie and Jeff Alker, Solutions Consultant, BusinessOptix, will explore how life sciences leaders can map and model processes to create end-to-end visibility, test scenarios before committing to automation, and establish ROI long before bots or AI are deployed.
The discussion will highlight AbbVie’s journey, in documenting their end-to-end clinical trial processes leveraging the BusinessOptix platform and how this sets them up for the next wave of innovation. Beyond technology, the speakers will address the human side of transformation, including organizational agility, change management and sustaining impact across the enterprise.
In today's data-centric world, making informed decisions is essential for achieving operational excellence. This session will highlight how organizations can harness data analytics and KPIs to enhance their decision-making processes.
Key Takeaways:
In today’s rapidly changing business environment, organizations face complex challenges such as geopolitics, tariffs, and supply chain disruptions. This session will explore how operational excellence enables businesses not just to survive but to thrive in an environment of continuous uncertainty by embedding resilience, agility, and proactive scenario planning into the core of their OPEX strategy.
Key Takeaways: